The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review
- PMID: 38873430
- PMCID: PMC11169809
- DOI: 10.3389/fphar.2024.1383359
The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review
Abstract
Introduction: In recent years, diverse initiatives have been carried out to control the COVID-19 pandemic, ranging from measures restricting social activities to analyzing drugs and vaccines. Studies on herbal medicines are also increasingly conducted in various countries as an adjuvant therapy or supplement. Therefore, this systematic review aimed to investigate the efficacy of herbal medicines analyzed from various countries through clinical trials with the randomized controlled trial method. The outcomes of Length of Stay (LOS), Negative Conversion Time (NCT), and Negative Conversion Rate (NCR) were the main focus.
Methods: An extensive review of literature spanning from 2019 to 2023 was carried out using well-known databases including PubMed, Scopus, and Cochrane. The search included relevant keywords such as "randomized controlled trial," "COVID-19," and "herbal medicine."
Results: A total of 8 articles were part of the inclusion criteria with outcomes of LOS, NCT, and NCR. In terms of LOS outcomes, all types of herbal medicines showed significant results, such as Persian Medicine Herbal (PM Herbal), Persian Barley Water (PBW), Jingyin Granules (JY granules), Reduning Injection, and Phyllanthus emblica (Amla). However, only JY granules showed significant results in NCR outcome, while JY granules and Reduning Injection showed significant results in reducing NCT.
Conclusion: These findings enrich our understanding of the potential benefits of herbal medicines in influencing LOS, NCR and NCT parameters in COVID-19 patients. Herbal medicines worked to treat COVID-19 through antiviral, anti-inflammatory, and immunomodulatory mechanisms.
Keywords: antiinflammatory; antiviral; clinical trial; herbal medicines; immunomodulatory; randomized controlled trial.
Copyright © 2024 Latarissa, Meiliana, Sormin, Sugiono, Wathoni, Barliana and Lestari.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus.Diabetes Metab Syndr Obes. 2025 Jan 16;18:135-146. doi: 10.2147/DMSO.S498774. eCollection 2025. Diabetes Metab Syndr Obes. 2025. PMID: 39840393 Free PMC article. Review.
-
Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019.Phytomedicine. 2023 Jan;108:154496. doi: 10.1016/j.phymed.2022.154496. Epub 2022 Oct 17. Phytomedicine. 2023. PMID: 36288651 Free PMC article. Clinical Trial.
-
The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial.Complement Ther Med. 2022 May;65:102808. doi: 10.1016/j.ctim.2022.102808. Epub 2022 Jan 29. Complement Ther Med. 2022. PMID: 35093510 Free PMC article. Clinical Trial.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Herbal Medicines for Treating Metabolic Syndrome: A Systematic Review of Randomized Controlled Trials.Evid Based Complement Alternat Med. 2016;2016:5936402. doi: 10.1155/2016/5936402. Epub 2016 Jun 19. Evid Based Complement Alternat Med. 2016. PMID: 27413388 Free PMC article. Review.
Cited by
-
Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine.Clin Pharmacol. 2025 Jan 16;17:1-11. doi: 10.2147/CPAA.S493750. eCollection 2025. Clin Pharmacol. 2025. PMID: 39845335 Free PMC article. Review.
-
Pharmacodynamic Modeling of Warfarin Dosing Algorithm for Cardiovascular Patients in Indonesia: A Tailored Method to Anticoagulation Therapy.Drug Des Devel Ther. 2025 Jan 29;19:671-681. doi: 10.2147/DDDT.S497738. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 39896937 Free PMC article.
-
The Efficacy of Oral/Intravenous Corticosteroid Use in COVID-19 Patients: A Systematic Review.J Exp Pharmacol. 2024 Oct 1;16:321-337. doi: 10.2147/JEP.S484596. eCollection 2024. J Exp Pharmacol. 2024. PMID: 39371262 Free PMC article. Review.
-
The Effect of Spinach (Amaranthus hybridus) on the Pharmacokinetic and Pharmacodynamic Profile of Warfarin in New Zealand White Rabbits.J Blood Med. 2025 Feb 17;16:75-82. doi: 10.2147/JBM.S490081. eCollection 2025. J Blood Med. 2025. PMID: 39991637 Free PMC article.
-
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus.Diabetes Metab Syndr Obes. 2025 Jan 16;18:135-146. doi: 10.2147/DMSO.S498774. eCollection 2025. Diabetes Metab Syndr Obes. 2025. PMID: 39840393 Free PMC article. Review.
References
-
- Amini S. Z., Shakeri N., Amini S. M., Mokaberinejad R., Hasheminasab F. S., Azimi M., et al. (2022). Evaluating the effect of a natural formulation based on hordeum vulgare on the recovery of COVID-19 patients: application of survival analysis in a clinical trial. Ann. Mil. Health Sci. Res. 20, 1–5. 10.5812/AMH-128009 - DOI
Publication types
LinkOut - more resources
Full Text Sources